Literature DB >> 1879532

Reversible expression of sm alpha-actin protein and sm alpha-actin mRNA in cloned cerebral endothelial cells.

A Amberger1, H Bauer, U Tontsch, G Gabbiani, O Kocher, H C Bauer.   

Abstract

The expression of smooth muscle (sm) alpha-actin was studied in cloned capillary cerebral endothelial cells of two phenotypes. Type I cells were cultured in medium containing 10% FCS, heparin and ECGS (or alpha-ECGF) and stained positive for a specific endothelial cell marker (Bandeiraea simplicifolia). Depletion of heparin and ECGS resulted in a smooth muscle-like appearance after 2-3 days. Cells of this phenotype, (type II) stained positive for the endothelial cell marker and for sm alpha-actin. In contrast to type I cells, type II cells expressed sm alpha-actin protein and mRNA as evidenced by Immunoblots and Northern blots. This phenotypic switch was shown to be reversible and so was the expression of sm alpha-actin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879532     DOI: 10.1016/0014-5793(91)80056-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats.

Authors:  S Nakatsuji; J Yamate; M Kuwamura; T Kotani; S Sakuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

2.  Heterogeneity of smooth muscle-associated proteins in mammalian brain microvasculature.

Authors:  E Ehler; G Karlhuber; H C Bauer; A Draeger
Journal:  Cell Tissue Res       Date:  1995-02       Impact factor: 5.249

3.  Actin is a surface component of calf pulmonary artery endothelial cells in culture.

Authors:  J Moroianu; J W Fett; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars.

Authors:  I E Willems; M G Havenith; J G De Mey; M J Daemen
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.